BELLEVUE, Wash., July 7, 2014 (GLOBE NEWSWIRE) -- mCig, Inc. (OTCQB:MCIG) is pleased to announce the continued expansion of its national media campaign. On June 30, 2014 the company signed an agreement with Joey Goodwin and John Gagliano of Good Days Marketing (GDM). Good Days Marketing is an innovative New York based mobile marketing and technology company that wraps its fleet of trucks with branded advertisements, video monitors, and live social media feeds. Over the last few years, New Yorkers have seen GDM trucks around the city marketing everything from sporting events to political candidates. The success of GDM campaigns has been noted by several national media outlets including: Forbes, New York Post, Elle, and others. To learn more about Joey, John, and Good Days Marketing visit: http://www.enjoygooddays.com/
"We are very excited to be working with Joey and John. Their type of guerrilla marketing is extremely successful given it simultaneously educates consumers with our message, while promoting and retailing our products. We believe that these activities are important and will hopefully cement VitaCig as the number one nicotine-free eCig brand in the world. We invite all our customers and shareholders to visit the VitaCig trucks and upload photos and videos on social media!", said Paul Rosenberg, CEO of mCig, Inc.
VitaCig Truck – High Impact Street Marketing
Beginning on July 17, 2014, GDM will be deploying a customized VitaCig Truck that will be fully covered in VitaCig graphics, Flat Screen TV's showing VitaCig videos 24/7, and WiFi technology based interactive marketing. Trucks will be operated by VitaCig "Models" who will be educating consumers on the benefits of VitaCig, retailing VitaCigs with Square, Inc. powered iPads, and giving out free samples. The ultimate goal of the campaign is to increase awareness for the VitaCig brand by reaching as many people as possible at sporting events, music concerts, and high foot-traffic areas. Current confirmed routes for the VitaCig trucks include:
Planned Route:
Thursday, July 17th - Union Square
Friday, July 18th - Times Square (NASDAQ Building)
Saturday, July 19th - Lower East Side
Sunday, July 20th - NYU /West Village
Thursday, July 24th - South Street Seaport
Friday, July 25th - Harlem
Saturday, July 26th - Yankee Stadium (Blue Jays vs. Yankees)
Sunday, July 27th - Meat Packing District (The Highline)
Thursday July 31st - Soho (Canal and Lafayette near VitaCig Billboard)
Friday August 1st - Central Park/Summer Stage (Near Apple Store)
Saturday August 2nd - Times Square
Sunday August 3rd - Union Square
Thursday August 7th - Wall Street
Friday, August 8th - Barclays Center/ Atlantic Avenue
Saturday, August 9th - Williamsburg, Brooklyn
Sunday, August 10th - Washington Square Park
Monday, August 11th - Flatiron
Thursday, August 14th - Madison Square Garden
Friday, August 15th - Union Square
Saturday, August 16th - Citi field (Cubs vs. Mets)
Sunday, August 17th - South Street Seaport
Monday, August 18th - Wall Street (New York Stock Exchange)
Thursday, August 21st - Flatiron
Friday, August 22nd - Meat Packing District (Standard Hotel)
Saturday, August 23rd - Lower East Side
Sunday, August 24th - Harlem
Monday, August 25th - Arthur Ashe Stadium US Open
Thursday, August 28th - Arthur Ashe Stadium US Open
Friday, August 29th - Arthur Ashe Stadium US Open
Saturday, August 30th - Times Square
Sunday, August 31st - Union Square
Monday, September 1st - NYU
Dates may be changed. Check the @VitaCig Twitter Feed for the most recent schedule.
About mCig, Inc.
mCig, Inc. (OTCQB:MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes, and (2) The adoption of electronic vaporizing cigarettes (commonly known as "eCigs") by the world's 1.2 Billion smokers. The company manufactures and retails the mCig – the world's most affordable vaporizer priced at only $10. Designed in the USA – the mCig provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc. which manufactures and retails home-use vaporizers such as the Vapolution 2.0. Through its wholly owned subsidiary, VitaCig, Inc., the company manufactures and retails the VitaCig, a $3 nicotine-free eCig that delivers a water-vapor mixed with vitamins and natural flavors. See more at: http://www.mCig.org/, www.Vapolution.com, and www.VitaCig.org
The company believes that a well regulated marijuana industry is emerging as more states follow the lead of Washington and Colorado in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 Billion over the next three years.
mCig, Inc. (OTCQB:MCIG) has positioned itself as a first mover at the intersection of these two trends and hopes to create shareholder value by making the mCig one of the leading choices for electronic consumption of plant material. - See more at: http://www.mcig.org/investors/investor-opportunity-subpage/
Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies.